Novel Coronavirus (SARS-CoV-2/COVID-19)
Health care providers are eligible for reimbursement from the federal government for COVID-19 testing, treatment and related services provided to the uninsured.
The Centers for Disease Control and Prevention last week released a new tool for estimating surges in demand for hospital-based services related to COVID-19.
Health care providers are eligible for reimbursement from the federal government for COVID-19 testing, treatment and related services provided to the uninsured. Starting today, April 27, providers, including hospitals and health systems, can register to participate with the Health Resources and…
The Centers for Medicare & Medicaid Services (CMS) April 26 announced it is reevaluating the amounts that will be paid under its Accelerated Payment Program and suspending its Advance Payment Program to Part B suppliers effective immediately.
Like the COVID-19 pandemic itself, access to protective gear for front-line health care workers is unevenly spread throughout the country. Some hospitals and health systems have adequate supplies of masks, gowns, gloves and other personal protective equipment on hand, while others have much more…
Rural communities’ patients are typically older than those in metro communities, and with the onset of COVID-19, many seniors are reluctant to leave their homes. Access to providers is strained as people avoid hospitals and clinics, yet are still in need of care. Wilson Medical Center (WMC) in…
This resource examines the impact of the social determinants of health on patients and communities as they battle the COVID-19 outbreak and shares ideas and case examples to help hospitals address ongoing social needs.
This resource highlights steps hospitals can and are taking to address disparities that arise during the fight against COVID-19.
AHA supports extending the Comprehensive Care for Joint Replacement model for an additional three years, but only on a voluntary basis, the association told the Centers for Medicare & Medicaid Services in comments submitted.
The Food and Drug Administration issued guidance allowing patients to use certain non-invasive fetal and maternal monitoring devices in the home during the COVID-19 emergency to reduce the need for in-clinic visits.